Anti-vertigo drug prescribing for patients with vestibular symptoms in primary care: a retrospective observational cohort study
Open Access
- 23 June 2025
- journal article
- Published by Royal College of General Practitioners in BJGP Open
- Vol. 9 (4)
Abstract
Background: There is limited evidence that anti-vertigo drugs (AVDs) are effective in patients with vestibular symptoms. Still, betahistine is one of the most frequently prescribed off-label drugs. GPs are likely to contribute substantially to these potentially inappropriate prescriptions. Aim: To evaluate the frequency of (long-term) AVD prescriptions in primary care and characteristics associated with long-term prescriptions. Design & setting: We conducted a retrospective observational cohort study using anonymised routine primary care data from ≥1.2 million patients registered at 269 general practices throughout the Netherlands, covering the period 2018–2021. Method: We included adult patients with vestibular symptoms and/or AVD prescriptions. Outcomes were the prevalence and incidence of (long-term) AVD prescriptions. We used a multivariable logistic regression analysis to identify characteristics associated with long-term prescriptions. Results: Among 66718 patients with vestibular symptoms, 6172 patients (9%) received AVD prescriptions of which 32% were long term. The majority of patients with prescriptions and long-term prescriptions (88% and 77%, respectively) had any other vestibular disorder than Ménière’s disease. Still, Ménière’s disease was associated with long-term prescriptions as well as increasing age. Patients with benign paroxysmal positional vertigo (BPPV) and a symptom diagnosis of lightheadedness were less likely to receive long-term prescriptions, in addition to patients registered at practices in extremely urbanised areas. Conclusion: AVD prescriptions, including long-term prescriptions, are common among patients with a wide array of vestibular symptoms and disorders, despite limited evidence. Management of vestibular symptoms by GPs can be improved by reducing these potentially inappropriate prescriptions.Keywords
This publication has 39 references indexed in Scilit:
- Systemic pharmacological interventions for Ménière’s diseaseCochrane Database of Systematic Reviews, 2023
- Long‐term benzodiazepines and z‐drug prescribing in Australian general practice between 2011 and 2018: A national studyPharmacology Research & Perspectives, 2021
- Betahistine for symptoms of vertigoCochrane Database of Systematic Reviews, 2016
- Vestibular rehabilitation for unilateral peripheral vestibular dysfunctionCochrane Database of Systematic Reviews, 2015
- The Epley (canalith repositioning) manoeuvre for benign paroxysmal positional vertigoCochrane Database of Systematic Reviews, 2014
- Drug, Patient, and Physician Characteristics Associated With Off-label Prescribing in Primary CareArchives of internal medicine (1960), 2012
- Frequency of ill‐founded off‐label prescribing in Dutch general practicePharmacoepidemiology and Drug Safety, 2008
- Burden of Dizziness and Vertigo in the CommunityArchives of internal medicine (1960), 2008
- Chelatietherapie onwerkzaamalternatieve geneeswijze journaalberichtHuisarts en wetenschap, 2002
- Betahistine for Ménière's disease or syndromeCochrane Database of Systematic Reviews, 2001